KMDA
Kamada Ltd.NASDAQHealthcare$8.47-2.24%ClosedMarket Cap: $488.6M
As of 2026-04-06
Valuation
P/E (TTM)
24.10
PEG
0.60
P/B
1.77
P/S
2.63
EV/EBITDA
10.90
DCF Value
$57.25
FCF Yield
3.3%
Div Yield
2.3%
Margins & Returns
Gross Margin
42.3%
Operating Margin
14.5%
Net Margin
11.2%
ROE
7.8%
ROA
5.4%
ROIC
6.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $45.6M | 38.0% | $3.6M | $3.6M | $0.06 | — |
| FY 2025 | $195.3M | 40.1% | $28.4M | $21.9M | $0.37 | $0.20 |
| Q3 2025 | $47.0M | 42.0% | $7.8M | $5.3M | $0.09 | — |
| Q2 2025 | $44.8M | 42.3% | $7.1M | $7.4M | $0.13 | — |
| Q1 2025 | $44.0M | 47.1% | $7.8M | $4.0M | $0.07 | $0.20 |
| Q4 2024 | $39.0M | 43.7% | $5.1M | $3.8M | $0.07 | — |
| FY 2024 | $161.0M | 43.5% | $20.1M | $14.5M | $0.25 | — |
| Q3 2024 | $41.7M | 41.3% | $5.3M | $3.9M | $0.07 | — |
| Q2 2024 | $42.5M | 44.6% | $5.6M | $4.4M | $0.08 | — |
| Q1 2024 | $37.7M | 44.4% | $4.0M | $2.4M | $0.04 | — |
| Q4 2023 | $36.4M | 39.6% | $2.8M | $5.1M | $0.09 | — |
| FY 2023 | $142.5M | 38.9% | $10.1M | $8.3M | $0.15 | — |